• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大甲状旁腺腺瘤:协调腺瘤大小与疾病表型的潜在机制。

Large parathyroid adenomas: Potential mechanisms to reconcile adenoma size and disease phenotype.

机构信息

Division of Endocrinology, Metabolism and Bone and Mineral Disorders, Henry Ford Health, Detroit, MI, United States.

Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

出版信息

Front Endocrinol (Lausanne). 2023 Feb 2;14:1009516. doi: 10.3389/fendo.2023.1009516. eCollection 2023.

DOI:10.3389/fendo.2023.1009516
PMID:36817587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9931720/
Abstract

Parathyroid adenomas weighing more than 3.5 g are reported variously as "atypical", "large" or "giant" parathyroid adenomas. All such adenomas are rare variants accounting for no more than 1.5% of all parathyroid adenomas. Large parathyroid adenomas are often associated with more severe form of the disease, including osteitis fibrosa cystica (OFC) and share many biochemical, histological, and molecular features of both benign and malignant parathyroid neoplasms, and are considered a distinct clinical entity. However, the pathogenesis of oversized parathyroid adenomas and the often-associated skeletal phenotype remains unclear. We present 5 cases of primary hyperparathyroidism (PHPT) with OFC, an uncommon manifestation of contemporary PHPT, associated with larger parathyroid adenomas, seen in the Bone and Mineral Disorders Clinic of the Henry Ford Health in the last 30 years to illustrate the critical role of vitamin D nutrition in the pathogenesis of both the OFC and adenoma size. The estimated prevalence of OFC was very low 0.2%, 5 of the >3000 surgically confirmed cases of PHPT seen during this time. The mean ± SD values were: age: 36.8 ± 22.1 years (4 of the 5 <36years), serum calcium 11.6 ± 1.1 mg/dl, alkaline phosphatase 799 ± 487 IU/L, PTH 1440 ± 477 pg/ml, 25-hydroxyvitamin D 13.0 ± 8.9 ng/ml, 1,25-dihyroxyvitamin D 26.5 ± 13.7 pg/ml, urine calcium 562 ± 274 mg/day, and parathyroid adenoma weight 4.53 ± 2.2 g. Parathyroidectomy led to the resolution of both the biochemical indices and OFC in each patient without recurrence over >10 years of follow-up. Because OFC is a very rare in the West, but very common areas of endemic vitamin D deficiency, we also examined the relationship between vitamin D nutrition, as assessed by serum 25-hydroxyvitamin D level, and parathyroid adenoma weight as well as prevalence of OFC in two large secularly diverse cohorts of patients with PHPT (Detroit, USA and Chandigarh, India). Based on this relationship and the relative prevalence of OFC in these two large cohorts, we propose that vitamin D nutrition (and perhaps calcium nutrition) best explains both the adenoma size and prevalence of OFC.

摘要

甲状旁腺腺瘤重量超过 3.5 克被报告为“非典型”、“大”或“巨大”甲状旁腺腺瘤。所有这些腺瘤都是罕见的变异,占所有甲状旁腺腺瘤的比例不超过 1.5%。大甲状旁腺腺瘤通常与更严重的疾病形式相关,包括纤维性骨炎囊性变(OFC),并具有良性和恶性甲状旁腺瘤的许多生化、组织学和分子特征,被认为是一种独特的临床实体。然而,超大甲状旁腺腺瘤的发病机制和常伴随的骨骼表型仍不清楚。我们报告了 5 例原发性甲状旁腺功能亢进症(PHPT)伴 OFC,这是当代 PHPT 的一种不常见表现,与更大的甲状旁腺腺瘤相关,这些病例均来自 Henry Ford Health 的骨骼和矿物质疾病诊所,在过去 30 年中观察到,以说明维生素 D 营养在 OFC 和腺瘤大小发病机制中的关键作用。OFC 的估计患病率非常低,为 0.2%,在这段时间内,超过 3000 例经手术证实的 PHPT 病例中只有 5 例。平均值±标准差为:年龄:36.8±22.1 岁(5 例中 4 例<36 岁),血清钙 11.6±1.1mg/dl,碱性磷酸酶 799±487IU/L,甲状旁腺素 1440±477pg/ml,25-羟维生素 D 13.0±8.9ng/ml,1,25-二羟维生素 D 26.5±13.7pg/ml,尿钙 562±274mg/天,甲状旁腺腺瘤重量 4.53±2.2g。甲状旁腺切除术使每位患者的生化指标和 OFC 都得到了缓解,且在 10 年以上的随访中无复发。由于 OFC 在西方非常罕见,但在维生素 D 缺乏的地方性流行地区非常常见,我们还研究了维生素 D 营养(通过血清 25-羟维生素 D 水平评估)与甲状旁腺腺瘤重量以及 PHPT 患者两个大型、具有时间差异的队列中 OFC 的患病率之间的关系(美国底特律和印度昌迪加尔)。基于这种关系以及这两个大队列中 OFC 的相对患病率,我们提出维生素 D 营养(或许还有钙营养)可以最好地解释腺瘤大小和 OFC 的患病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/5a60001fcb7a/fendo-14-1009516-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/4cc5faa2cf8d/fendo-14-1009516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/a382a3f7c093/fendo-14-1009516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/e0125f566987/fendo-14-1009516-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/5a60001fcb7a/fendo-14-1009516-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/4cc5faa2cf8d/fendo-14-1009516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/a382a3f7c093/fendo-14-1009516-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/e0125f566987/fendo-14-1009516-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb17/9931720/5a60001fcb7a/fendo-14-1009516-g004.jpg

相似文献

1
Large parathyroid adenomas: Potential mechanisms to reconcile adenoma size and disease phenotype.大甲状旁腺腺瘤:协调腺瘤大小与疾病表型的潜在机制。
Front Endocrinol (Lausanne). 2023 Feb 2;14:1009516. doi: 10.3389/fendo.2023.1009516. eCollection 2023.
2
Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective.维生素D和钙营养在原发性甲状旁腺功能亢进症疾病表现及甲状旁腺肿瘤生长中的作用:全球视角
J Bone Miner Res. 2002 Nov;17 Suppl 2:N75-80.
3
Brown tumor due to primary hyperparathyroidism in a familial case: a case report.家族性原发性甲状旁腺功能亢进致棕色瘤 1 例报告。
BMC Endocr Disord. 2023 Oct 8;23(1):214. doi: 10.1186/s12902-023-01475-3.
4
Vitamin D status in primary hyperparathyroidism in India.印度原发性甲状旁腺功能亢进症患者的维生素D状况
Clin Endocrinol (Oxf). 1995 Sep;43(3):351-8. doi: 10.1111/j.1365-2265.1995.tb02043.x.
5
Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications.维生素D营养状况对甲状旁腺腺瘤重量的影响:发病机制及临床意义
J Clin Endocrinol Metab. 2000 Mar;85(3):1054-8. doi: 10.1210/jcem.85.3.6440.
6
Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中维生素D状态与生化/临床及病理参数之间的相关性。
World J Surg. 2006 Mar;30(3):321-6. doi: 10.1007/s00268-005-0239-y.
7
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.原发性甲状旁腺功能亢进症中的维生素D状态、季节变化、甲状旁腺腺瘤重量和骨密度
Clin Endocrinol (Oxf). 2005 Nov;63(5):506-13. doi: 10.1111/j.1365-2265.2005.02371.x.
8
Osteitis Fibrosa Cystica and pathological fractures-the classic but neglected skeletal manifestation of primary hyperparathyroidism: a case report.纤维囊性骨炎和病理性骨折——原发性甲状旁腺功能亢进症的经典但被忽视的骨骼表现:一例报告。
BMC Musculoskelet Disord. 2021 May 14;22(1):443. doi: 10.1186/s12891-021-04326-1.
9
Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism.预防原发性和肾性甲状旁腺功能亢进患者甲状旁腺切除术后的饥饿骨综合征
Diagnostics (Basel). 2023 Jun 2;13(11):1953. doi: 10.3390/diagnostics13111953.
10
Oxyphil parathyroid adenoma: a malignant presentation of a benign disease.嗜酸性甲状旁腺腺瘤:一种良性疾病的恶性表现。
J Clin Endocrinol Metab. 2004 Dec;89(12):5948-51. doi: 10.1210/jc.2004-1597.

引用本文的文献

1
A giant parathyroid adenoma: a case report.巨大甲状旁腺腺瘤:一例报告。
J Med Case Rep. 2024 Nov 14;18(1):552. doi: 10.1186/s13256-024-04897-2.
2
Unusual clinical presentation of a giant parathyroid adenoma: A case report from Morocco highlighting the rare entity and atypical symptoms.巨大甲状旁腺腺瘤的不寻常临床表现:来自摩洛哥的一例病例报告,凸显了这种罕见疾病及非典型症状。
SAGE Open Med Case Rep. 2024 Sep 3;12:2050313X241272624. doi: 10.1177/2050313X241272624. eCollection 2024.
3
Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis.

本文引用的文献

1
Overview of the 2022 WHO Classification of Parathyroid Tumors.《2022 年世卫组织甲状旁腺肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17.
2
Giant parathyroid tumours in primary hyperparathyroidism: a systematic review.原发性甲状旁腺功能亢进中的巨大甲状旁腺肿瘤:系统综述。
Langenbecks Arch Surg. 2022 Mar;407(2):501-516. doi: 10.1007/s00423-021-02406-3. Epub 2022 Jan 18.
3
Parathyroid Tumors: Molecular Signatures.甲状旁腺肿瘤:分子特征。
维生素 D 缺乏对 cyclin D1 诱导甲状旁腺肿瘤发生的影响。
Endocrinology. 2023 Sep 23;164(11). doi: 10.1210/endocr/bqad137.
Int J Mol Sci. 2021 Oct 18;22(20):11206. doi: 10.3390/ijms222011206.
4
Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.PAX1 表达的异常表观遗传改变导致甲状旁腺肿瘤发生。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e783-e792. doi: 10.1210/clinem/dgab626.
5
GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.甲状旁腺腺瘤中 GCM2 的沉默与启动子超甲基化和组蛋白 3 上的甲基化增加有关。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4084-e4096. doi: 10.1210/clinem/dgab374.
6
Differences in Primary Hyperparathyroidism Between Pre- and Postmenopausal Women in India.印度绝经前和绝经后妇女原发性甲状旁腺功能亢进症的差异。
Endocr Pract. 2021 Jul;27(7):710-715. doi: 10.1016/j.eprac.2020.12.012. Epub 2020 Dec 29.
7
A detailed appraisal of renal manifestations in primary hyperparathyroidism from Indian PHPT registry: Before and after curative parathyroidectomy.对印度原发性甲状旁腺功能亢进症登记处中肾脏表现的详细评估:甲状旁腺切除术前后。
Clin Endocrinol (Oxf). 2021 Mar;94(3):371-376. doi: 10.1111/cen.14311. Epub 2020 Sep 3.
8
Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.甲状旁腺腺瘤中钙敏感受体(CaSR)表达减少是表观遗传失调所致。
J Clin Endocrinol Metab. 2020 Sep 1;105(9):3015-24. doi: 10.1210/clinem/dgaa419.
9
Effect of vitamin D nutrition on disease indices in patients with primary hyperparathyroidism.维生素 D 营养对原发性甲状旁腺功能亢进症患者疾病指标的影响。
J Steroid Biochem Mol Biol. 2020 Jul;201:105695. doi: 10.1016/j.jsbmb.2020.105695. Epub 2020 May 12.
10
Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors.散发性甲状旁腺肿瘤中失调的丝裂原活化蛋白激酶通路导致细胞周期紊乱。
J Endocrinol Invest. 2020 Feb;43(2):247-253. doi: 10.1007/s40618-019-01098-3. Epub 2019 Sep 18.